Webinar Archive

Research Series

ICR Logo Icon PNG

Dr. Marsha Rosner, Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses

ICR Logo Icon PNG

Dr. Simon Haroutounian, Cannabinoids for pain: Is effectiveness in the eye of the beholder?

ICR Logo Icon PNG

Dr. Yasmin Hurd, Cannabis and Neurodevelopmental Vulnerability: What do we really know

ICR Logo Icon PNG

Dr. Staci Gruber, Medical Cannabis Use: What to Keep in Mind

ICR Logo Icon PNG

Dr. Edgar Alfonso Romero-Sandoval, The legal cannabis market in the context of pain patients and community factors

ICR Logo Icon PNG

Dr. Angela Bryan, Implication of Cannabis for Obesity-Related Processes and Behaviors: Anecdotes versus Data

It seems we can't find what you're looking for.
ICR Logo Icon PNG

Dr. Susan Weiss, Cannabis Research and Policy: State of the Science

October 2021

Dr. Susan Weiss is the Director, Division of Extramural Research at the National Institute on Drug Abuse (NIDA), which oversees NIDA’s extramural programs, operations planning, and trans-NIH initiatives, such as the Adolescent Brain Cognitive Development (ABCD®) and HEALthy Brain Child Development (HBCD) studies, and the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. Dr. […]

Read More »
ICR Logo Icon PNG

Dr. Ziva Cooper, Human Studies Probing Cannabis Constitutents for Pain Relief: Looking Beyond Delta-9-THC

July 2021

Dr. Ziva Cooper is the Director of the UCLA Cannabis Research Initiative in the Jane and Terry Semel Institute for Neuroscience and Human Behavior and Associate Professor in the Department of Psychiatry and Biobehavioral Sciences and Department of Anesthesiology at the David Geffen School of Medicine. Her current research involves understanding variables that influence […]

Read More »
ICR Logo Icon PNG

Dr. Clayton W. Snell, A Deep Dive Into Epidiolex

June 2021

Dr. Clayton W. Snell is the Senior Medical Science Liaison at Greenwich Biosciences (now part of Jazz Pharmaceuticals) and holds a Doctor of Pharmacy (PharmD) from the University of the Sciences in Philadelphia and possesses experience in professional medical affairs, healthcare services, and a demonstrated history in the pharmaceutical industry.

Dr. Clayton W. Snell, Cannabis […]

Read More »
ICR Logo Icon PNG

Ajay Nayak & George Hodgin, Academic and Business Perspectives of Compliance in Cannabis Research

May 2021

George Hodgin

Title: Access to Federally Compliant Cannabis for Research
George Hodgin is the Founder and CEO of Biopharmaceutical Research Company (BRC), an applicant with the Drug Enforcement Administration to produce federally compliant cannabis products for research. BRC holds several DEA Schedule I Registrations and engages in compliant cannabis research. He is a former Navy SEAL […]

Read More »
ICR Logo Icon PNG

Dr. Cristina Sempio , Cannabinoids and Endocannabinoids in Human Breast Milk

April 2021

The Institute of Cannabis Research’s monthly webinar for April 2021 featured Dr. Cristina Sempio. Dr. Sempio is a Research Instructor in the Department of Anesthesiology at the University of Colorado Anschutz Medical Campus. She earned her PhD in forensic sciences at the University of Verona (Italy), developing cutting-edge analytical methods for the screening and quantification of […]

Read More »